RxSight chief business development officer Eric Weinberg sells $14,205 in stock By Investing.com
NVE Corp director Daniel Baker sells $182,250 in shares By Investing.com

Daniel A. Baker, a director at NVE Corp (), sold shares of the company’s common stock totaling $182,250 on August 17, 2026, according to a recent SEC filing.
Mr. Baker disposed of 1,500 shares at a price of $121.50 per share. Following this transaction, Mr. Baker directly holds 44,803 shares of NVE Corp common stock.The insider sale comes as NVEC shares trade at $111.28, below Baker’s transaction price, though the stock has delivered an impressive 94.2% return year-to-date. According to InvestingPro analysis, the stock currently appears overvalued relative to its Fair Value estimate. The company maintains a dividend yield of 3.59% and has paid dividends for 12 consecutive years, one of several key insights available in NVEC’s comprehensive Pro Research Report.
In other recent news, NVE Corporation reported significant financial results for the first quarter of 2026. The company saw an 81% increase in revenue, reaching $11.0 million, compared to the previous year. Additionally, NVE Corporation’s net income rose by 79% to $6.39 million, with diluted earnings per share increasing to $1.32 from $0.74. These results indicate a substantial growth trajectory for the company. Analysts have taken note of the company’s performance, with some suggesting that new product launches could be contributing to this accelerated growth. The earnings report highlights a marked improvement from NVE Corporation’s typical quarterly revenue, which usually ranges between $6 million and $7 million. These developments have caught the attention of investors and analysts alike.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
